R. Morlock

Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia

J. Mintz, D. Velligan, L. Alphs, 2009, Psychiatry Research.

Validation of a 4‐item Negative Symptom Assessment (NSA‐4): a short, practical clinical tool for the assessment of negative symptoms in schizophrenia

A. Szegedi, L. Alphs, C. Coon, 2011, International journal of methods in psychiatric research.

Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.

W. Horan, J. Geraci, F. Butlen-Ducuing, 2022, Innovations in clinical neuroscience.

The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief Training.

L. Alphs, C. Coon, A. V. van Willigenburg, 2010, Psychiatry (Edgmont (Pa. : Township)).

COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general population.

E. Heidari, R. Morlock, Carolyn Brown, 2022, Journal of managed care & specialty pharmacy.

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes

L. Lerer, B. Lerer, R. Matzopoulos, 2022, Frontiers in Psychiatry.

Physician observations and perceptions of positive and negative symptoms of schizophrenia: A multinational, cross-sectional survey

Y. Lecrubier, O. Leeuwenkamp, G. Milligan, 2007, European Psychiatry.

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes

L. Lerer, B. Lerer, R. Matzopoulos, 2021, Frontiers in Psychiatry.